keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cyclo(-RGDfK) (Cyclo (-RGDfK)) 是一种选择性整合素αvβ3的有效抑制剂,IC50值为 0.94 nM。它通过与细胞表面的 αvβ3 整合素结合,特异性靶向肿瘤微血管和癌细胞。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 442 | 现货 | ||
5 mg | ¥ 975 | 现货 | ||
10 mg | ¥ 1,516 | 现货 | ||
25 mg | ¥ 2,970 | 现货 | ||
50 mg | ¥ 3,930 | 现货 | ||
100 mg | ¥ 5,630 | 现货 | ||
500 mg | ¥ 11,600 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,297 | 现货 |
产品描述 | Cyclo(-RGDfK) (Cyclo (-RGDfK)) is an effective and specific αvβ3 integrin inhibitor. |
靶点活性 | αvβ3:0.94 nM. |
体外活性 | Cyclo (-RGDfK-) has a high affinity for purified integrin (Kd: 41.70 nM). It is reacting with HEK293(β3) cells moderately. The micelles modified by Cyclo(-RGDfK-) show strong affinity to T-24 cells and strong inhibitory effect on the proliferation of T-24 cells. |
体内活性 | In athymic mice bearing α(v)β(3)-integrin-positive C6 gliomas, Cyclo (-RGDfK-) modification induces less tumor metabolic activity, less tumor progression, fewer intratumoral vessels. |
激酶实验 | Isolated Integrin Binding Assays.:Purified integrin (1 μg/mL; 4℃) is used to coat 96-well microtitre plates, which are then blocked with bovine serum albumin (BSA) (3% in 1 mM CaCl2, 1 mM MgCl2,10 pM MnCl2, 100 mM NaC1,50 mM Tris-hydroxymethyl-aminomethane; pH 7.4), and incubated (3 h at 30 ℃) with biotinylated ligands (1 pg/mL in binding buffer: 0.1% BSA, 1 mM CaCl2,1 mM MgCl2, 10 μM MnCl2, 100 mM NaCl, 50 mM Tris-hydroxymethyl-aminomethane; pH 7.4) in the presence or absence of serially diluted peptides. After washing (3×5 min with binding buffer), the bound biotinylated ligand is detected with alkaline-phosphatase conjugated goat anti-biotin antibodies (1 μg/mL; 1 h, 37℃), using p-nitrophenyl phosphate as chromogen. Cyclo (-RGDfK) binding in the absence of competitor is defined as 100% signal; binding to blocked wells in the absence of integrin is defined as 0%. Concentrations of Cyclo (-RGDfK) required for 50% inhibition of signal (IC50 values) are estimated graphically. |
别名 | Cyclo (-RGDfK) |
分子量 | 603.67 |
分子式 | C27H41N9O7 |
CAS No. | 161552-03-0 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 80 mg/mL(111.5 mM)
Ethanol: 84 mg/mL (117.04 mM)
DMSO: 100 mg/mL (139.33 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / Ethanol / DMSO | 1 mM | 1.6565 mL | 8.2827 mL | 16.5653 mL | 41.4134 mL |
5 mM | 0.3313 mL | 1.6565 mL | 3.3131 mL | 8.2827 mL | |
10 mM | 0.1657 mL | 0.8283 mL | 1.6565 mL | 4.1413 mL | |
20 mM | 0.0828 mL | 0.4141 mL | 0.8283 mL | 2.0707 mL | |
50 mM | 0.0331 mL | 0.1657 mL | 0.3313 mL | 0.8283 mL | |
100 mM | 0.0166 mL | 0.0828 mL | 0.1657 mL | 0.4141 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cyclo(-RGDfK) 161552-03-0 Cytoskeletal Signaling Integrin inhibit Microvasculature Cyclo (-RGDfK) Cyclo cancer tumoral cell αvβ3 integrin Cyclo(RGDfK) ligand Inhibitor -RGDfK Cyclo( RGDfK) inhibitor